The Readout Loud
Un pódcast de STAT - Jueves
350 Episodo
-  Episode 189: Biogen, Biogen, Biogen, with a dash of OmicronPublicado: 9/12/2021
-  Episode 188: Carlos del Rio on Covid antivirals, an FDA conundrum, & the rise of OmicronPublicado: 2/12/2021
-  Episode 187: Biogen’s scientific succession & Michael Osterholm on pandemic ThanksgivingPublicado: 18/11/2021
-  Episode 186: Rebecca Robbins on Moderna v. NIH, plus psilocybin as a medicinePublicado: 11/11/2021
-  Episode 185: John Maraganore on his next act, plus Moderna's setback & the drug pricing reform sagaPublicado: 4/11/2021
-  Episode 184: Vaccines for kids, inside Operation Warp Speed, & a big biotech resignationPublicado: 28/10/2021
-  Episode 183: Greg Zuckerman on the vaccine race, plus Biogen's troubled launchPublicado: 21/10/2021
-  Episode 182: The FDA star search, more booster debates, & the future of mRNAPublicado: 14/10/2021
-  Episode 181: Brent Hodge on filming Shkreli, the next NIH director, and a looming FDA deadlinePublicado: 7/10/2021
-  Episode 180: Health equity 'tourism,' an $11B biopharma acquisition, & a bony Covid protestPublicado: 30/9/2021
-  Episode 179: Scott Gottlieb on the next pandemic, another Covid winter, & Aduhelm's slow rolloutPublicado: 23/9/2021
-  Episode 178: Futuristic prosthetics, a treatment for ALS, & intrigue at the Holmes trialPublicado: 16/9/2021
-  Episode 177: Bijan Salehizadeh on Covid tests, plus Verily's moment of truthPublicado: 9/9/2021
-  Episode 176: Elizabeth Holmes on trial, FDA in disarray, & the quest for Covid antiviralsPublicado: 2/9/2021
-  Episode 175: Dorit Reiss on vaccine mandates, plus biotech's messy summerPublicado: 26/8/2021
-  Episode 174: Biotech's trust issues, overwhelmed health workers, & the nuances of insider tradingPublicado: 19/8/2021
-  Episode 173: Biden's drug pricing plan, Wall Street's Alzheimer's fixation, & daily 5 a.m. alarmsPublicado: 12/8/2021
-  Episode 172: The mRNA gold rush, Delta's alarming rise, & the next treatment for Alzheimer'sPublicado: 5/8/2021
-  Episode 171: The quest for a Covid pill, a microbiome gut-check, & CRISPR on the big screenPublicado: 29/7/2021
-  Episode 170: Céline Gounder on breakthrough infections, plus the power of lobbyingPublicado: 22/7/2021
STAT’s weekly biotech podcast, breaking down the latest news, digging deep into industry goings-on, and giving you a preview of the week to come.
